Fig. 1.
Flowchart of patient selection. EGFR-TKI epidermal growth factor receptor–tyrosine kinase inhibitor, NSCLC non-small cell lung cancer, PD progressive disease
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.